SYSTEMATIC REVIEW article
Front. Endocrinol.
Sec. Obesity
Volume 16 - 2025 | doi: 10.3389/fendo.2025.1690754
This article is part of the Research TopicGeno-phenotype Specific Molecular Targets for Therapeutic Developments in PancreatitisView all articles
Metabolic Syndrome Components Individually Worsen the Outcome of Acute Pancreatitis: A Systematic Review and Meta-analysis
Provisionally accepted- 1Institute for Translational Medicine, Medical School, University of Pécs, Pécs, Hungary
- 2Centre for Translational Medicine, Semmelweis University, Budapest, Hungary
- 3Department of Restorative Dentistry and Endodontics, Semmelweis University, Budapest, Hungary
- 4Department of Biophysics and Radiation Biology, Semmelweis University, Budapest, Hungary
- 5Institute of Pancreatic Diseases, Semmelweis University, Budapest, Hungary
- 6Department of Pharmacology and Pharmacotherapy, Semmelweis University, Budapest, Hungary
- 7Center for Pharmacology and Drug Research & Development, Semmelweis University, Budapest, Hungary
- 8Translational Pancreatology Research Group, Interdisciplinary Centre of Excellence for 20 Research Development and Innovation, University of Szeged, Szeged, Hungary
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Introduction: The obesity epidemic has led to a rise in related health conditions, with metabolic syndrome (MS) affecting 25% of Western populations. In severe acute pancreatitis (AP), mortality can reach 50%. Previous studies have linked MS elements to increased complications and mortality in AP. This meta-analysis aims to identify potential risk factors and their synergistic effects on AP outcomes. Methods: We systematically searched PubMed, Embase, and the Cochrane Library up to November 1, 2023, and included studies based on predefined criteria. We examined the impact of MS and its factors (obesity, hypertension, diabetes mellitus, and hypertriglyceridemia) on AP outcomes, calculating pooled odds ratios (OR) with 95% confidence intervals (CIs). The protocol was registered in PROSPERO under number CRD42023471092. Results: Out of 15,904 records, 89 studies were analyzed. Overweight and obesity were significant risk factors for complications (local OR: 2.677, 95%CI: 1.421-5.044; systemic OR: 2.404, 95%CI: 1.481-3.901) and severe AP (BMI≥30 kg/m2, OR: 3.058, 95%CI: 1.369-6.829). High triglyceride levels were associated with ICU admission (OR: 2.546, 95%CI: 1.529-4.237) and severe AP (OR: 2.686, 95%CI: 1.205-5.989); hypertension increased mortality (OR: 2.135, 95%CI: 1.870-2.437), while diabetes increased the odds of ICU admission (OR: 1.645, 95%CI: 1.358-1.992) and severe AP (OR: 1.49, 95%CI: 1.09-2.03). We found a non-significant trend toward increased odds of severe AP among patients with MS (OR = 1.398, 95% CI: 0.918–2.129). Conclusion: Individual components of MS are risk factors for complications, severity, and mortality in AP. Lifestyle counseling, education, and treatment of patients with obesity is crucial.
Keywords: acute, Pancreatitis, metabolic, syndrome, Obesity, diabetes, Hypertriglyceridemia, Hypertension
Received: 22 Aug 2025; Accepted: 20 Oct 2025.
Copyright: © 2025 Dobszai, Obeidat, Szalai, Veres, Havelda, Papp, Choi, Budai, Csajbók, Hegyi and Szentesi. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Andrea Szentesi, szentesiai@gmail.com
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.